British Journal of Dermatology

Aims & Scope

The BJD strives to publish the highest-quality dermatological research.

In so doing, the Journal aims to advance the understanding, management and treatment of skin disease in order to improve the outcomes of patient care.

The main focus of the BJD (described in a position statement published in the June 2015 issue) is to publish the highest-quality research encompassing the following: Clinical trials that are registered before recruitment starts and report fully according to the CONSORT guidelines.

Clinical studies that include epidemiology, qualitative research and mixed methods that conform to the STROBE and SRQR reporting guidelines.

Translational research that describes basic and applied science of potential clinical relevance.

Systematic reviews following the PRISMA statement (http://www.prisma-statement.org/ ), MOOSE guidelines or the ENTREQ statement.

The BJD invites submissions under a broad scope of topics relevant to clinical and experimental research as described in the position statement.

The Journal publishes original articles, Reviews, Clinical Guidelines, Research Letters, Perspectives, Case Reports and items of correspondence.

The BJD is an official organ of the British Association of Dermatologists, but attracts contributions from dermatology researchers throughout the world.

The BJD editorial board and editorial team include outstanding clinical academics, scientists and clinicians from across the globe.

The circulation and readership of the BJD are equally international.

The overriding criteria for publication are scientific merit, originality and interest to a multidisciplinary audience.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	9.6
2024	11.00

Journal Rank

Year	Value
2024	986

Journal Citation Indicator

Year	Value
2024	5177

SJR (SCImago Journal Rank)

Year	Value
2024	2.459

Quartile

Year	Value
2024	Q1

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• A systematic review of worldwide incidence of nonmelanoma skin cancer

  Citation: 1472

  Authors: A., J., F.

• Classification of the cutaneous manifestations of <scp>COVID</scp> ‐19: a rapid prospective nationwide consensus study in Spain with 375 cases

  Citation: 978

  Authors: C., A., G., P., D., A., I., R., D., M., J., O., C., V., X., I., G., J., X., A., M., P., J., M., I.

• The epidemiology of skin cancer

  Citation: 921

  Authors: T.L., V.

• The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis..

  Citation: 863

  Authors: H.C., P.G., R.J., C.B., M.J., J.J., E.A., A.Y., A.C., R.A., D.A., M.S., C.A., J.I., R.H., T.F., J., T.J.

• Cellular and molecular mechanisms of repair in acute and chronic wound healing

  Citation: 827

  Authors: P., R.

• AN ACUTE FEBRILE NEUTROPHTLIC DERMATOSTS.

  Citation: 825

  Authors: R. B.

• Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?

  Citation: 790

  Authors: S.H., A., L., S., B.B., M., J.C.

• Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study

  Citation: 747

  Authors: S.H., P., L., Y., C.Y., D., A., L., M., J.C.

• The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use

  Citation: 745

  Authors: M.S., A.Y.

• The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation

  Citation: 722

  Authors: H.C., P.G., A.C., R.J.

---